Comment on CMS-2026-1255-0001

Summary: The Infusion Access Foundation supports the proposed rule to modernize prior authorization and improve interoperability for drugs, particularly for patients requiring infusion and injection therapies. They argue that while electronic prior authorization is a positive step, CMS must ensure it reduces administrative burdens, provides clear transparency on denials, and supports continuity of care for chronic conditions.